About Us

About AccuTheranostics™

AccuTheranostics™ is a biotechnology company focused on the business of individualizing chemotherapy thereby dramatically improving outcomes for cancer patients.

AccuTheranostics™ uses proprietary sophisticated technologies to provide patient-specific cancer diagnostic and prognostic information to oncologists in hospitals and oncology practices.

AccuTheranostics™ is a leader in delineating the entire cellular composition of solid tumors. Specimens are shipped in AccuTheranostics’™ holding medium to our headquarters in Buffalo, New York where they undergo disaggregation, are subjected to drugs, single and in combination, and chemoresistance/sensitive profile is determined.  The results will be provided within days of receiving the specimen to determine optimum treatment.

AccuTheranostics™ is committed to advancing the science and practice of oncology therapeutics, with a strong emphasis on improving patient outcomes, enhancing patient quality and quantity of life.

Mission

To revolutionize personalized chemotherapy for cancer patients.

Vision

Respected leader in the discovery and
development of breakthrough medicines.

Core Values

Principles and standards that are most important to our company.